Surface vacuolar ATPase in ameloblastoma contributes to tumor invasion of the jaw bone

  • Authors:
    • Shohei Yoshimoto
    • Hiromitsu Morita
    • Ryota Matsubara
    • Takeshi Mitsuyasu
    • Yuko Imai
    • Shunichi Kajioka
    • Masahiro Yoneda
    • Yushi Ito
    • Takao Hirofuji
    • Seiji Nakamura
    • Masato Hirata
  • View Affiliations

  • Published online on: January 19, 2016     https://doi.org/10.3892/ijo.2016.3350
  • Pages: 1258-1270
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Ameloblastoma is the most common benign odontogenic tumor in Japan. It is believed that it expands in the jaw bone through peritumoral activation of osteoclasts by receptor activator of nuclear factor kappa-B ligand (RANKL) released from the ameloblastoma, as in bone metastases of cancer cells. However, the clinical features of ameloblastoma, including its growth rate and patterns of invasion, are quite different from those of bone metastasis of cancer cells, suggesting that different underlying mechanisms are involved. Therefore, in the present study, we examined the possible mechanisms underlying the invasive expansion of ameloblastoma in the jaw bone. Expression levels of RANKL assessed by western blotting were markedly lower in ameloblastoma (AM-1) cells than in highly metastatic oral squamous cell carcinoma (HSC-3) cells. Experiments coculturing mouse macrophages (RAW264.7) with AM-1 demonstrated low osteoclastogenic activity, as assessed by tartrate-resistant acid phosphatase (TRAP)-positive multinuclear cell formation, probably because of low release of RANKL, whereas cocultures of RAW264.7 with HSC-3 cells exhibited very high osteoclastogenic activity. Thus, RANKL release from AM-1 appeared to be too low to generate osteoclasts. However, AM-1 cultured directly on calcium phosphate-coated plates formed resorption pits, and this was inhibited by application of bafilomycin A1. Furthermore, vacuolar-type H+-ATPase (V-ATPase) and H+/Cl- exchange transporter 7 (CLC-7) were detected on the surface of AM-1 cells by plasma membrane biotinylation and immunofluorescence analysis. Immunohistochemical analysis of clinical samples of ameloblastoma also showed plasma membrane-localized V-ATPase and CLC-7 in the epithelium of plexiform, follicular and basal cell types. The demineralization activity of AM-1 was only 1.7% of osteoclasts demineralization activity, and the growth rate was 20% of human normal skin keratinocytes and HSC-3 cells. These results suggest that the slow expansion of several typical types of ameloblastomas in jaw bone is attributable to its slow growth and low demineralization ability.
View Figures
View References

Related Articles

Journal Cover

March 2016
Volume 48 Issue 3

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Yoshimoto, S., Morita, H., Matsubara, R., Mitsuyasu, T., Imai, Y., Kajioka, S. ... Hirata, M. (2016). Surface vacuolar ATPase in ameloblastoma contributes to tumor invasion of the jaw bone. International Journal of Oncology, 48, 1258-1270. https://doi.org/10.3892/ijo.2016.3350
MLA
Yoshimoto, S., Morita, H., Matsubara, R., Mitsuyasu, T., Imai, Y., Kajioka, S., Yoneda, M., Ito, Y., Hirofuji, T., Nakamura, S., Hirata, M."Surface vacuolar ATPase in ameloblastoma contributes to tumor invasion of the jaw bone". International Journal of Oncology 48.3 (2016): 1258-1270.
Chicago
Yoshimoto, S., Morita, H., Matsubara, R., Mitsuyasu, T., Imai, Y., Kajioka, S., Yoneda, M., Ito, Y., Hirofuji, T., Nakamura, S., Hirata, M."Surface vacuolar ATPase in ameloblastoma contributes to tumor invasion of the jaw bone". International Journal of Oncology 48, no. 3 (2016): 1258-1270. https://doi.org/10.3892/ijo.2016.3350